An Investigation of the Effects of Tiagabine on GABA using Magnetic Resonance Spectroscopy.
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Tiagabine (Primary)
- Indications Anxiety; Epilepsy
- Focus Pharmacodynamics
- 15 Aug 2012 Accrual to date is 116% according to United Kingdom Clinical Research Network.
- 25 Jul 2011 Status changed from recruiting to completed as reported by UKCRN.
- 22 Jul 2011 United Kingdom Clinical Research Network reports accrual date changed from 66% to 166%.